Dysregulation of nitric oxide synthase activity and Bcl-2 and caspase-3 gene expressions in renal tissue of streptozotocin-induced diabetic rats

Turkish Journal of Medical Sciences

Volumn 42, Issue 5, 2012, Pages 830-838

  Aktuǧ, Hüseyin ^a   Bozok Çetintaş, Vildan ^a   Kosova, Buket ^a   Oltulu, Fatih ^a   Bakti Demiray, Şirin ^a   Çavuşoǧlu, Türker ^a   Akarca, Saadet Özen ^a   Yavaşoǧlu, Altuǧ ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Bcl 2; Caspase 3; Diabetes mellitus; eNOS; iNOS

Indexed keywords

CASPASE 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROTEIN BCL 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 84864109912     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1104-38     Document Type: Article

References (31)

1. Thomson SC, Deng A, Bao D, Satriano J, Blantz RC, Vallon V. Ornithine decarboxylase, kidney size, and the tubular hypothesis of glomerular hyperfi ltration in experimental diabetes. J Clin Invest 2001; 107: 217-24.
2. Kosova B, Çetintaş VB, Yavaşoǧlu A, Altay B, Aktuǧ H. From a molecular biological viewpoint, does endothelin type A receptor antagonist therapy reduce diabetes-induced testicular damage in rats? Urology 2011; 77: 250. e7-13.
3. O'Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 1997; 17: 93-100.
4. Hostetter TH. Hyperfi ltration and glomerulosclerosis. Semin Nephrol 2003; 23: 194-9.
5. Breyer MD, Bottinger E, Brosius FC 3rd, Coffman TM, Harris RC, Heilig CW et al. Mouse models of diabetic nephropathy. J Am Soc Nephrol 2005; 16: 27-45.
6. Navar LG. Integrating multiple paracrine regulators of renal microvascular dynamics. Am J Physiol 1998; 274: 433-44.
7. Mattson DL, Roman RJ, Cowley AW. Role of nitric oxide in renal papillary blood fl ow and sodium excretion. Hypertension 2001; 19: 766-9.
8. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocininduced diabetes. Am J Physiol Heart Circ Physiol 2005; 289: 2144-52.
9. Desagher S, Martinou JC. Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000; 10: 369-77.
10. Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of type I diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes 2000; 49: 708-11.
11. Keren P, George J, Shaish A, Levkovitz H, Janakovic Z, Afek A et al. Effect of hyperglycemia and hyperlipidemia on atherosclerosis in LDL receptor-defi cient mice: establishment of a combined model and association with heat shock protein 65 immunity. Diabetes 2000; 49: 1064-9.
12. Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun 1999; 13: 383-92.
13. Wong FS, Janeway CA Jr. Insulin-dependent diabetes mellitus and its animal models. Curr Opin Immunol 1999; 11: 643-7.
14. Sugano M, Yamato H, Hayashi T, Ochiai H, Kakuchi J, Goto S et al. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutr Metab Cardiovasc Dis 2006; 16: 477-84.
15. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A. Amelioration of vascular dysfunction in diabetic rats by an oral protein kinase beta inhibitor. Science 1996; 272: 728-31.
16. Veelken R, Hilgers KF, Hartner A, Haas A, Böhmer KP, Sterzel RB. Nitric oxide synthase isoforms and glomerular hyperfi ltration in early diabetic nephropathy. J Am Soc Nephrol 2000; 11: 71-9.
17. Trachtman H, Futterweit S, Pine E, Mann J, Valderrama E. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol 2002; 17: 20-9.
18. Xu R, Morales JA, Muniyappa R, Skafar DF, Ram JL, Sowers JR. IL-1-induced nitric oxide production in rat aortic endothelial cells: inhibition by estradiol in normal and high glucose cultures. Life Sci 1999; 64: 2451-62.
19. Noh H, Ha H, Yu MR, Kang SW, Choi KH, Han DS et al. High glucose increases inducible NO production in cultured rat mesangial cells. Possible role in fi bronectin production. Nephron 2002; 90: 78-85.
20. Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant 2008; 4: 1346-54.
21. Sharma K, Danoff TM, DePiero A, Ziyadeh FN. Enhanced expression of inducible nitric oxide synthase in murine macrophages and glomerular mesangial cells by elevated glucose levels: possible mediation via protein kinase C. Biochem Biophys Res Commun 1995; 207: 80-8.
22. Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221-32.
23. Han KH, Lim JM, Kim WY, Kim H, Madsen KM, Kim J. Expression of endothelial nitric oxide synthase in developing rat kidney. Am J Physiol Renal Physiol 2005; 288: 694-702.
24. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130: 963-74.
25. Ono H, Ono Y, Takanohashi A, Matsuoka H, Frohlich ED. Apoptosis and glomerular injury after prolonged nitric oxide synthase inhibition in spontaneously hypertensive rats. Hypertension 2001; 38: 1300-6.
26. Busse R, I Fleming. Pulsatile stretch and shear stress: physical stimuli determining the production of endothelium derived relaxing factors. J Vasc Res 1998; 35: 73-84.
27. Choi KC, Kim NH, An MR, Kang DG, Kim SW, Lee J. Alterations of intrarenal renin-angiotensin and nitric oxide systems in streptozotocin-induced diabetic rats. Kidney Int 1997; 60: S23-7.
28. Sugimoto H, Shikata K, Matsuda M, Kushiro M, Hayashi Y, Hiragushi K et al. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in aff erent and glomerular endothelial cells is involved in glomerular hyperfi ltration of diabetic nephropathy. Diabetologia 1998; 41: 1426-34.
29. Keynan S, Hirshberg B, Levin-Iaina N, Wexler ID, Dahan R, Reinhartz E et al. Renal nitric oxide production during the early phase of experimental diabetes mellitus. Kidney Int 2000; 58: 740-7.
30. Baker AJ, Mooney A, Hughes J, Lombardi D, Johnson RJ, Savill J. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 1994; 94: 2105-16.
31. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota A. Apoptosis in glomerular sclerosis. Kidney Int 1996; 49: 103-11.